Silsesquioxane derivative, curable composition, cured product, hard coating agent, hard coat, article, and laminate
The use of a silsesquioxane derivative with specific properties creates a hard coat with excellent adhesion and weather resistance on cycloolefin (co)polymer substrates, addressing the challenges of low scratch resistance and poor adhesion, and eliminating the need for high-temperature heating in existing methods.
Patent Information
- Application Number
- PCT/JP2024/018229
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-31
- Filing Date
- 2024-05-16
- Publication Date
- 2024-12-05
AI Technical Summary
Cycloolefin (co)polymer substrates have low scratch resistance and poor adhesion, making it difficult to apply a hard coat without pretreatment, and existing methods require high-temperature heating, which is inefficient and impractical.
A silsesquioxane derivative with a condensation rate of 72.0% or more and a curing shrinkage rate of less than 8.9% is used to create a curable composition that forms a hard coat with excellent adhesion and weather resistance on difficult-to-adhesive substrates without high-temperature heat treatment.
The silsesquioxane derivative provides a hard coat with improved adhesion and weather resistance to cycloolefin (co)polymer substrates, enhancing their scratch resistance and productivity by eliminating the need for high-temperature heating.
Smart Images

Figure JP2024018229_05122024_PF_FP_ABST
Abstract
Description
Silsesquioxane derivative, curable composition, cured product, hard coating agent, hard coating, article, and laminate
[0001] The present disclosure relates to a silsesquioxane derivative, a curable composition, a cured product, a hard coating agent, a hard coating, an article, and a laminate.
[0002] For example, cycloolefin (co)polymer substrates are used as substrates for optical applications. The term "cycloolefin (co)polymer substrate" refers to at least one of a substrate containing a cycloolefin copolymer and a substrate containing a cycloolefin polymer. The surface of a cycloolefin (co)polymer substrate has the disadvantage of being easily scratched due to its low scratch resistance. To prevent scratches, a hard coat is applied to the surface of the cycloolefin (co)polymer substrate. However, cycloolefin (co)polymer substrates are generally known to be one of the poorly adhesive substrates. There have been few reports of techniques for forming a well-adhering hard coat on the surface of a cycloolefin (co)polymer substrate without pretreatment (e.g., plasma treatment, primer treatment, etc.). Furthermore, coating agents are required to be durable so that their performance does not deteriorate even when used in a variety of environments.
[0003] Organic-inorganic hybrid materials such as silsesquioxane derivatives are known as highly durable hard coats. For example, hard coats for cycloolefin (co)polymer substrates can be obtained by curing hard coat agents containing alkoxysilanes or their hydrolysates through a sol-gel reaction caused by heating.
[0004] Patent Document 1 discloses that a coating composition (hereinafter also referred to as a "hard coating composition") is coated on a cycloolefin (co)polymer, and the coating film is cured by a sol-gel method by heating at 140° C. for 1 hour. The hard coating composition contains an organoalkoxysilane, its hydrolysate or partial hydrolysate, colloidal silica, water, and a hydrophilic organic solvent.
[0005] Patent Document 2 lists norbornene-based resins and cycloolefin-based resins as substrate materials. In the examples, it is disclosed that a curable composition (hereinafter also referred to as a "hard coating composition") is coated on a substrate base material (glass chip or silicon chip), and the coating film is cured by a sol-gel method by heating at 170°C for 2 hours. The hard coating composition contains a silsesquioxane derivative having a phenyl group and a methyl group, silica fine particles, and a silane coupling agent.
[0006] Patent Document 1: JP 3-122137 A Patent Document 2: WO 2021 / 060562
[0007] However, the methods disclosed in Patent Documents 1 and 2 require high-temperature heating for curing after coating the hard coating composition on a substrate. Therefore, the substrate needs to be heat-resistant to these heating temperatures. In addition, the curing takes time, resulting in low productivity and making the methods impractical.
[0008] The present disclosure has been made in view of the above circumstances. An object of one embodiment of the present disclosure is to provide a silsesquioxane derivative, a curable composition, a cured product, a hard coating agent, a hard coating, an article, and a laminate that have excellent adhesion and weather resistance to poorly adhesive substrates (e.g., cycloolefin (co)polymer substrates) even without high-temperature heat treatment.
[0009] The present disclosure includes the following aspects: <1> A silsesquioxane derivative represented by the following formula (1), having a condensation rate of 72.0% or more and a cure shrinkage rate of less than 8.9%.
[0010]
[0011] In formula (1), R 1 and R 2 are each independently an alkylene group having 1 to 10 carbon atoms, a cycloalkylene group having 3 to 10 carbon atoms, an arylene group having 6 to 10 carbon atoms, or an aralkylene group having 7 to 12 carbon atoms; R 3 is an alkyl group having 1 to 6 carbon atoms, and R 4 and R5 are each independently a hydrogen atom, a saturated or unsaturated alkyl group having 1 to 20 carbon atoms, a saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an aralkyl group having 7 to 20 carbon atoms; R 6 is an organic group having 2 to 12 carbon atoms and at least one of an ethylenically unsaturated bond and a carbon-carbon triple bond, and R 7 and R 8 are each independently an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, or an aralkyl group having 7 to 10 carbon atoms, and a plurality of R 5 may be the same or different, and multiple R 7 may be the same or different, and multiple R 8 may be the same or different, R 1 ~R 8 may each independently be partially substituted with a substituent or a halogen atom, and t, u, v, w, x, y, and z each independently represent 0 or a positive number, with at least one of u and v being a positive number. <2> The silsesquioxane derivative according to <1>, wherein u is a positive number, and v, x, and y are each independently 0 or a positive number. <3> The silsesquioxane derivative according to <1>, wherein u and v are each independently a positive number. <4> A curable composition comprising the silsesquioxane derivative according to any one of <1> to <3> and a polymerization initiator. <5> A cured product obtained by curing the curable composition according to <4>. <6> A hard coating agent comprising the curable composition according to <4>. <7> A hard coating obtained by curing the hard coating agent according to <6>. <8> An article (preferably a substrate) having the hard coating according to <7>. <9> A laminate having the hard coating according to <7> and a substrate. <10> The laminate according to <9>, wherein the substrate contains an olefin polymer.
[0012] According to one embodiment of the present disclosure, it is possible to provide a silsesquioxane derivative, a curable composition, a cured product, a hard coating agent, a hard coating, an article, and a laminate that have excellent adhesion and weather resistance to poorly adhesive substrates even when not subjected to high-temperature heat treatment.
[0013] Hereinafter, embodiments of the present disclosure will be described in detail, but the present disclosure is not limited to the following embodiments.
[0014] In the present disclosure, numerical ranges indicated using "to" include the numerical values before and after "to" as the minimum and maximum values, respectively. In numerical ranges described in stages in the present disclosure, the upper or lower limit value described in one numerical range may be replaced with the upper or lower limit value of another staged numerical range. In numerical ranges described in this specification, the upper or lower limit value of that numerical range may be replaced with a value shown in the examples. In the present disclosure, when multiple substances corresponding to each component are present in the composition, the amount of each component in the composition means the total amount of the corresponding multiple substances present in the composition, unless otherwise specified. In the present disclosure, the term "step" includes not only independent steps, but also steps that cannot be clearly distinguished from other steps, as long as the intended purpose of the step is achieved. In the present disclosure, "mass %" and "wt %" are synonymous, and "parts by mass" and "parts by weight" are synonymous.
[0015] The "high temperature" in "high-temperature heat treatment" refers to, for example, a temperature applied to promote the sol-gel reaction that hardens the coating agent. The high temperature is, for example, 120°C or higher, and preferably 130°C or higher. If the temperature of the high-temperature heat treatment is higher than the softening temperature of the substrate, it is not preferable to form a cured product on the substrate using the coating agent.
[0016] <Silsesquioxane Derivative> The silsesquioxane derivative of the present disclosure is represented by the following formula (1), and has a condensation rate of 72.0% or more and a cure shrinkage rate of less than 8.9%.
[0017]
[0018] In formula (1), R 1 and R 2 are each independently an alkylene group having 1 to 10 carbon atoms, a cycloalkylene group having 3 to 10 carbon atoms, an arylene group having 6 to 10 carbon atoms, or an aralkylene group having 7 to 12 carbon atoms; R 3 is an alkyl group having 1 to 6 carbon atoms, and R 4 and R 5 are each independently a hydrogen atom, a saturated or unsaturated alkyl group having 1 to 20 carbon atoms, a saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an aralkyl group having 7 to 20 carbon atoms; R 6 is an organic group having 2 to 12 carbon atoms and at least one of an ethylenically unsaturated bond and a carbon-carbon triple bond, and R 7 and R 8 are each independently an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, or an aralkyl group having 7 to 10 carbon atoms, and a plurality of R 5 may be the same or different, and multiple R 7 may be the same or different, and multiple R 8 may be the same or different, R 1 ~R 8 may each independently be partially substituted with a substituent or a halogen atom, and t, u, v, w, x, y, and z each independently represent 0 or a positive number, and at least one of u and v is a positive number.
[0019] The mechanism by which the silsesquioxane derivative of the present disclosure exerts the above-described effects is not clear, but is presumed to be as follows. By setting the condensation rate of the silsesquioxane derivative to a predetermined value or higher, the silsesquioxane derivative contains an appropriate amount of hydroxyl groups and alkoxy groups. As a result, the silsesquioxane derivative has low polarity and improved hydrophobicity. This is presumed to improve the adhesion between a cured product (hereinafter simply referred to as a "cured product") obtained by curing the silsesquioxane derivative of the present disclosure and a poorly adhesive substrate (e.g., a hydrophobic substrate). By setting the cure shrinkage rate of the silsesquioxane derivative to less than a predetermined value, the interfacial stress of the cured product is reduced. Therefore, it is presumed that the cured product exhibits excellent adhesion and weather resistance to poorly adhesive substrates.
[0020] In the present disclosure, R in formula (1) 1 ~R 8 may each independently be partially substituted with a substituent or a halogen atom. 1 ~R 8 may each independently be partially substituted with an alkyl group, an aryl group, an aralkyl group, a vinyl group, an epoxy group, an oxetanyl group, a hydroxyl group, an amino group, an alkylamino group, an arylamino group, an aralkylamino group, an ammonium group, a thiol group, an isocyanurate group, a ureido group, an isocyanate group, a carboxy group, an acid anhydride group, or a halogen atom. 1 ~R 8 may each independently be unsubstituted. For example, R 1 ~R 3 or R 6 ~R 8 (Preferably, R 1 ~R 3 and R 6 ~R 8 ) may be unsubstituted.
[0021] Hereinafter, the constituent units that may be contained in the silsesquioxane derivative of the present disclosure will be referred to as (a) to (g) as follows.
[0022]
[0023] In the silsesquioxane derivative of the present disclosure, in formula (1), t, u, v, w, x, y, and z are each independently 0 or a positive number, and at least one of u and v is a positive number. In other words, the silsesquioxane derivative of the present disclosure includes at least one of the structural units (b) and (c) among the structural units (a) to (g) described above, and optionally includes at least one of the structural units (a), (d), (e), (f), and (g).
[0024] In formula (1), t represents the molar ratio of structural unit (a) to 100 moles of structural units (a) to (g) (hereinafter also referred to as "total structural units"). u represents the molar ratio of structural unit (b) to 100 moles of all structural units. v represents the molar ratio of structural unit (c) to 100 moles of all structural units. w represents the molar ratio of structural unit (d) to 100 moles of all structural units. x represents the molar ratio of structural unit (e) to 100 moles of all structural units. y represents the molar ratio of structural unit (f) to 100 moles of all structural units. z represents the molar ratio of structural unit (g) to 100 moles of all structural units. For example, the molar ratio can be determined from the NMR (nuclear magnetic resonance) analysis value of the silsesquioxane derivative of the present disclosure. When the reaction rate of each raw material of the silsesquioxane derivative is known or when the yield is 100%, the molar ratio can be determined from the amount of the raw material charged. For example, the molar ratio of each structural unit of the silsesquioxane derivative can be calculated by the amount of the raw material charged, for example, for a sample dissolved in deuterated chloroform or the like. 1 H-NMR analysis is carried out, and further analysis is carried out as necessary. 29 The molar ratio may also be calculated by Si-NMR analysis. The silsesquioxane derivative may be decomposed into its constituent units using an alkali or the like, and the structure of the silsesquioxane derivative may be estimated from the ratio of the constituent units. If necessary, the molar ratio of each constituent unit of the silsesquioxane derivative may be determined by combining known techniques (for example, mass spectrometry or IR (infrared absorption spectroscopy) analysis, etc.).
[0025] Each of the structural units (b) to (g) in formula (1) may be of only one type, or may be of two or more types. The arrangement order in formula (1) indicates the composition of the structural units, but does not refer to the arrangement order of the silsesquioxane derivative. Therefore, the condensation form of the structural units in the silsesquioxane derivative of the present disclosure does not have to be the arrangement order of formula (1). The structural units (a) to (g) are described in detail below.
[0026] <<Structural Unit (a)>> The structural unit (a) of the present disclosure is a Q unit. A “Q unit” is a unit in which O is bonded to one silicon atom. 1/2 It means a unit having four (two oxygen atoms).
[0027] The proportion of the structural unit (a) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, from the viewpoint of adhesiveness and weather resistance, the molar ratio of the structural unit (a) to all structural units (t / (t+u+v+w+x+y+z)) is preferably 0.1 or less, more preferably 0.05 or less, and even more preferably 0. "A molar ratio of 0" means that the corresponding structural unit is not contained, and the same applies hereinafter.
[0028] <<Structural Unit (b)>> The structural unit (b) of the present disclosure is R 1 The term "T unit" refers to a unit in which an acryloyloxy group is bonded to a silicon atom via O. 1/2 It means a unit having three (1.5 oxygen atoms).
[0029] In the structural unit (b), R 1 is an alkylene group having 1 to 10 carbon atoms, a cycloalkylene group having 3 to 10 carbon atoms, an arylene group having 6 to 10 carbon atoms, or an aralkylene group having 7 to 12 carbon atoms. 1 is preferably an alkylene group having 1 to 10 carbon atoms or a cycloalkylene group having 3 to 10 carbon atoms, and more preferably an alkylene group having 1 to 10 carbon atoms.
[0030] The alkylene group having 1 to 10 carbon atoms is preferably an alkylene group having 1 to 6 carbon atoms, more preferably an alkylene group having 2 to 4 carbon atoms, and even more preferably a propylene group. The alkylene group having 1 to 10 carbon atoms may be linear or branched. The cycloalkylene group having 3 to 10 carbon atoms is preferably a cycloalkylene group having 3 to 6 carbon atoms, and more preferably a cycloalkylene group having 4 to 6 carbon atoms. The cycloalkylene group having 3 to 10 carbon atoms may be branched.
[0031] The proportion of the structural unit (b) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, the molar ratio of the structural unit (b) to all structural units (u / (t+u+v+w+x+y+z)) is preferably 0.20 to 0.99, more preferably 0.30 to 0.90, even more preferably 0.30 to 0.70, and particularly preferably 0.45 to 0.65, from the viewpoints of the condensation rate and cure shrinkage rate. The molar ratio of the structural unit (b) to all structural units may be 0.
[0032] From the viewpoint of adhesion and weather resistance, it is preferable to satisfy u > v. It is more preferable to satisfy 0 < molar ratio of structural unit (b) (u / (t + u + v + w + x + y + z)) - molar ratio of structural unit (c) (v / (t + u + v + w + x + y + z)) ≦ 1. It is even more preferable to satisfy 0.05 ≦ molar ratio of structural unit (b) (u / (t + u + v + w + x + y + z)) - molar ratio of structural unit (c) (v / (t + u + v + w + x + y + z)) ≦ 0.60. It is particularly preferable to satisfy 0.10 ≦ molar ratio of structural unit (b) (u / (t + u + v + w + x + y + z)) - molar ratio of structural unit (c) (v / (t + u + v + w + x + y + z)) ≦ 0.40.
[0033] <<Structural Unit (c)>> The structural unit (c) of the present disclosure is R 2 The hydrogen atom is connected to R 3 The T unit is a T unit in which an acryloyloxy group (such as a methacryloyloxy group) substituted with the above is bonded to a silicon atom.
[0034] In the structural unit (c), R 2is an alkylene group having 1 to 10 carbon atoms, a cycloalkylene group having 3 to 10 carbon atoms, an arylene group having 6 to 10 carbon atoms, or an aralkylene group having 7 to 12 carbon atoms. 2 A preferred embodiment of the present invention is R 1 is the same as:
[0035] In the structural unit (c), R 3 is an alkyl group having 1 to 6 carbon atoms. Examples of the alkyl group having 1 to 6 carbon atoms include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, and a hexyl group. A methyl group or an ethyl group is preferred, and a methyl group is more preferred.
[0036] The proportion of the structural unit (c) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, the molar ratio of the structural unit (c) to all structural units (v / (t+u+v+w+x+y+z)) is preferably 0 to 0.80, more preferably 0.05 to 0.70, even more preferably 0.20 to 0.70, and particularly preferably 0.35 to 0.55, from the viewpoints of the condensation rate and cure shrinkage rate. The molar ratio of the structural unit (c) to all structural units may be 0.
[0037] In formula (1), at least one of u and v is a positive number. From the viewpoint of cure shrinkage, it is preferable that u and v are each independently a positive number.
[0038] From the viewpoint of adhesiveness and weather resistance, the total molar ratio of the structural units (b) and (c) ((u+v) / (t+u+v+w+x+y+z)) to all structural units is preferably 0.3 to 1.0, more preferably 0.5 to 1.0, even more preferably 0.7 to 1.0, and particularly preferably 0.9 to 1.0.
[0039] <<Structural Unit (d)>> The structural unit (d) of the present disclosure is R 4 is a T unit bonded to the silicon atom.
[0040] In the structural unit (d), R 4is a hydrogen atom, a saturated or unsaturated alkyl group having 1 to 20 carbon atoms, a saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an aralkyl group having 7 to 20 carbon atoms.
[0041] The saturated or unsaturated alkyl group having 1 to 20 carbon atoms may be linear or branched. The saturated or unsaturated alkyl group having 1 to 20 carbon atoms is preferably a saturated or unsaturated alkyl group having 1 to 10 carbon atoms, and more preferably a saturated alkyl group having 1 to 10 carbon atoms.
[0042] Examples of saturated alkyl groups having 1 to 10 carbon atoms include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl groups. From the viewpoints of heat resistance and hardness of the cured product, methyl and ethyl groups are preferred, and methyl groups are more preferred.
[0043] Examples of the unsaturated alkyl group having 1 to 10 carbon atoms include a vinyl group, a 2-propenyl group, and an ethynyl group.
[0044] The saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms may be branched. The saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms is preferably a saturated or unsaturated cycloalkyl group having 4 to 6 carbon atoms.
[0045] The aryl group having 6 to 20 carbon atoms is preferably an aryl group having 6 to 10 carbon atoms.
[0046] Examples of the aryl group having 6 to 20 carbon atoms include a phenyl group, a group in which one or more hydrogen atoms of a phenyl group are substituted with an alkyl group having 1 to 10 carbon atoms, and a naphthyl group. From the viewpoints of heat resistance and hardness of the cured product, a phenyl group is preferred.
[0047] The aralkyl group having 7 to 20 carbon atoms is preferably an aralkyl group having 7 to 10 carbon atoms.
[0048] Examples of aralkyl groups having 7 to 20 carbon atoms include groups in which one hydrogen atom of an alkyl group having 1 to 10 carbon atoms is substituted with an aryl group (e.g., a phenyl group). Examples of aralkyl groups having 7 to 20 carbon atoms include a benzyl group or a phenethyl group. From the viewpoints of heat resistance and hardness of the cured product, a benzyl group is preferred.
[0049] R 4 When a part of the structure represented by R is substituted with a substituent or a halogen atom, R 4 Examples of the alkyl group include a 3-glycidoxypropyl group, a 2-(3,4-epoxycyclohexyl)ethyl group, a 3-(3-ethyloxetan-3-yl)methoxypropyl group, a 3-hydroxypropyl group, a 3-aminopropyl group, a 3-dimethylaminopropyl group, a 3-hydroxypropyl group, a 3-aminopropyl hydrochloride salt, a 3-dimethylaminopropyl hydrochloride salt, a p-styryl group, an N-2-(aminoethyl)-3-aminopropyl group, an N-phenyl-3-aminopropyl group, an N-(vinylbenzyl)-2-aminoethyl-3-aminopropyl hydrochloride salt, a 3-ureidopropyl group, a 3-mercaptopropyl group, a 3-isocyanatopropyl group, a 3-carboxypropyl group, and a 3-chloropropyl group.
[0050] The proportion of the structural unit (d) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, from the viewpoints of adhesiveness and weather resistance, the molar ratio of the structural unit (d) to all structural units (w / (t+u+v+w+x+y+z)) is preferably 0.10 or less, more preferably 0.05 or less, and even more preferably 0.
[0051] <<Structural Unit (e)>> The structural unit (e) is a unit having two R 5 is a D unit in which O is bonded to a silicon atom. 1/2 It means a unit having two (one as an oxygen atom).
[0052] In the structural unit (e), R 5is a hydrogen atom, a saturated or unsaturated alkyl group having 1 to 20 carbon atoms, a saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an aralkyl group having 7 to 20 carbon atoms. 5 may be the same or different. 5 A preferred embodiment of the present invention is R 4 is the same as:
[0053] The proportion of the structural unit (e) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, from the viewpoint of adhesiveness and weather resistance, the molar ratio of the structural unit (e) to all structural units (x / (t+u+v+w+x+y+z)) is preferably 0.4 or less, more preferably 0.3 or less, more preferably 0.2 or less, even more preferably 0.1 or less, and even more preferably 0. On the other hand, from the viewpoint of cure shrinkage, x is preferably a positive number.
[0054] <<Structural Unit (f)>> The structural unit (f) of the present disclosure is a unit selected from the group consisting of one R 6 and two R 5 is an M unit in which O is bonded to a silicon atom. 1/2 It means a unit having one oxygen atom (0.5 oxygen atoms).
[0055] In the structural unit (f), R 6 is an organic group having 2 to 12 carbon atoms and at least one of an ethylenically unsaturated bond and a carbon-carbon triple bond.
[0056] Examples of the organic group having 2 to 12 carbon atoms and an ethylenically unsaturated bond include a vinyl group, an orthostyryl group, a metastyryl group, a parastyryl group, an acryloyloxymethyl group, a methacryloyloxymethyl group, a 2-acryloyloxyethyl group, a 2-methacryloyloxyethyl group, a 3-acryloyloxypropyl group, a 3-methacryloyloxypropyl group, an 8-acryloyloxyoctyl group, and an 8-methacryloyloxyoctyl group.
[0033] Examples of suitable silsesquioxane derivatives include vinyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 3-butenyl, 1-pentenyl, 4-pentenyl, 3-methyl-1-butenyl, 1-phenylethenyl, 2-phenylethenyl, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 3-butynyl, 1-pentynyl, 4-pentynyl, 3-methyl-1-butynyl, and phenylbutynyl. From the viewpoint of hardness when the silsesquioxane derivative is cured, vinyl, 2-propenyl, orthostyryl, metastyryl, and parastyryl groups are preferred, and vinyl is more preferred.
[0057] In the structural unit (f), R 7 is an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, or an aralkyl group having 7 to 10 carbon atoms. 7 may be the same or different from each other.
[0058] Examples of the alkyl group having 1 to 10 carbon atoms include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, and a decyl group. From the viewpoints of heat resistance and hardness of the cured product, a methyl group or an ethyl group is preferred, and a methyl group is more preferred.
[0059] Examples of the aryl group having 6 to 10 carbon atoms include a phenyl group, a group in which one or more hydrogen atoms of a phenyl group are substituted with an alkyl group having 1 to 4 carbon atoms, and a naphthyl group. From the viewpoints of heat resistance and hardness of the cured product, a phenyl group is preferred.
[0060] Examples of aralkyl groups having 7 to 10 carbon atoms include groups in which one hydrogen atom of an alkyl group having 1 to 4 carbon atoms is substituted with an aryl group (e.g., a phenyl group). Examples of aralkyl groups having 7 to 10 carbon atoms include a benzyl group or a phenethyl group. From the viewpoints of heat resistance and hardness of the cured product, a benzyl group is preferred.
[0061] The proportion of the structural unit (f) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, from the viewpoints of adhesiveness and weather resistance, the molar ratio of the structural unit (f) to all structural units (y / (t+u+v+w+x+y+z)) is preferably 0.3 or less, more preferably 0.2 or less, and even more preferably 0.1 or less.
[0062] <<(Structural Unit (g)>> The structural unit (g) is a unit having three R 8 is the M unit bonded to the silicon atom.
[0063] In the structural unit (g), R 8 is an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, or an aralkyl group having 7 to 10 carbon atoms. 8 may be the same or different. 8 A preferred embodiment of the present invention is R 7 is the same as:
[0064] The proportion of the structural unit (g) in the silsesquioxane derivative of the present disclosure is not particularly limited. For example, from the viewpoints of adhesiveness and weather resistance, the molar ratio of the structural unit (g) to all structural units (z / (t+u+v+w+x+y+z)) is preferably 0.10 or less, more preferably 0.05 or less, and even more preferably 0.
[0065] <<Other Structural Unit (h)>> The silsesquioxane derivative of the present disclosure may further include (R 9 O 1/2 ) (hereinafter also referred to as structural unit (h)). 9is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. The alkyl group having 1 to 6 carbon atoms may be either an aliphatic group or an alicyclic group, and may be either linear or branched. Examples of the alkyl group having 1 to 6 carbon atoms include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, and a hexyl group.
[0066] The structural unit (h) is an alkoxy group, which is a hydrolyzable group contained in the silicon compound described below, or an alkoxy group generated by substitution of the hydrolyzable group of the silicon compound with an alcohol contained in the reaction solvent. The structural unit (h) may be one that remains in the molecule without being hydrolyzed or polycondensed. The structural unit (h) may be a hydroxyl group that remains in the molecule after hydrolysis without being polycondensed.
[0067] In formula (1), it is preferable that t and z are 0, and w, x, and y are each independently 0 or a positive number, and it is more preferable that t, w, x, y, and z are 0. In formula (1), it is preferable that 0≦y / (u+v+w)≦0.5 is satisfied. It is more preferable that 0≦y / (u+v+w)≦0.3 is satisfied. It is even more preferable that 0≦y / (u+v+w)≦0.2 is satisfied.
[0068] In formula (1), it is preferred that u is a positive number, and v, x and y are each independently 0 or a positive number.
[0069] In formula (1), it is preferable that u and v are each independently a positive number. It is preferable that u and v are each independently a positive number and satisfy 0.1≦v / u≦1. It is more preferable that 0.2≦v / u≦1. It is even more preferable that 0.3≦v / u≦1.
[0070] (Condensation rate) The condensation rate of the silsesquioxane derivative of the present disclosure is 72.0% or more. From the viewpoint of adhesion and weather resistance, the condensation rate is preferably 75.0% or more, and more preferably 78.0% or more. The condensation rate is preferably 98% or less, more preferably 95% or less, and even more preferably 90% or less. If the condensation rate is less than 72.0%, the adhesion will decrease. By having a condensation rate of 98% or less, it is easy to maintain good viscosity, solubility in solvents, and / or coatability, and the adhesion will be more excellent.
[0071] The condensation rate of the silsesquioxane derivative of the present disclosure is 29 The condensation ratio can be calculated from the ratio of peak integral values of M1 units, D1 units, D2 units, T1 units, T2 units, T3 units, Q1 units, Q2 units, Q3 units, and Q4 units in Si-NMR (nuclear magnetic resonance) measurement. Specifically, the condensation ratio is calculated according to the following formulas (a) to (c).
[0072] Formula (a): Condensation rate (%) = [integral value of silicon corresponding to condensed siloxane bonds / integral value of silicon corresponding to all condensable siloxane bonds] x 100 For example, the integral value of the T3 unit is represented as [T3]. Formula (b): Integral value of silicon corresponding to condensed siloxane bonds = [M1] x 1 + [D1] x 1 + [D2] x 2 + [T1] x 1 + [T2] x 2 + [T3] x 3 + [Q1] x 1 + [Q2] x 2 + [Q3] x 3 + [Q4] x 4 Formula (c): Integral value of silicon corresponding to all condensable siloxane bonds = ([M0] + [M1]) x 1 + ([D0] + [D1] + [D2]) x 2 + ([T0] + [T1] + [T2] + [T3]) x 3 + ([Q0] + [Q1] + [Q2] + [Q3] + [Q4]) x 4
[0073] In the formula, [M0] and [M1] are the silsesquioxane derivatives 29 In the Si-NMR spectrum, the peak integral values of silicon atoms assigned to M0 and M1 are shown below. The silicon atoms assigned to M0 and M1 are silicon atoms assigned to a monofunctional organosilicon compound. [D0], [D1], and [D2] are the peak integral values of the silsesquioxane derivative. 29In the Si-NMR spectrum, the peak integral values of silicon atoms assigned to D0, D1, and D2 below are silicon atoms assigned to the bifunctional organosilicon compound. [T0], [T1], [T2], and [T3] are the peak integral values of the silicon atoms assigned to the silsesquioxane derivative. 29 In the Si-NMR spectrum, the peak integral values of silicon atoms assigned to the following T0, T1, T2, and T3 are silicon atoms assigned to the trifunctional organosilicon compound. [Q0], [Q1], [Q2], [Q3], and [Q4] are the peak integral values of the silicon atoms assigned to the silsesquioxane derivative. 29 In the Si-NMR spectrum, the peak integral values of silicon atoms assigned to Q0, Q1, Q2, Q3, and Q4 below are shown. The silicon atoms assigned to Q0, Q1, Q2, Q3, and Q4 below are silicon atoms assigned to a tetrafunctional organosilicon compound. M0: A silicon atom that is not bonded to other silicon atoms via oxygen. M1: A silicon atom that is bonded to one silicon atom via oxygen. D0: A silicon atom that is not bonded to other silicon atoms via oxygen. D1: A silicon atom that is bonded to one silicon atom via oxygen. D2: A silicon atom that is bonded to two silicon atoms via oxygen. T0: A silicon atom that is not bonded to other silicon atoms via oxygen. T1: A silicon atom that is bonded to one silicon atom via oxygen. T2: A silicon atom that is bonded to two silicon atoms via oxygen. T3: A silicon atom that is bonded to three silicon atoms via oxygen. Q0: A silicon atom that is not bonded to other silicon atoms via oxygen. Q1: A silicon atom that is bonded to one silicon atom via oxygen. Q2: A silicon atom that is bonded to two silicon atoms via oxygen. Q3: A silicon atom that is bonded to three silicon atoms via oxygen. Q4: A silicon atom that is bonded to four silicon atoms via oxygen.
[0074] (Curing shrinkage) The curing shrinkage of the silsesquioxane derivative of the present disclosure is less than 8.9%. From the viewpoint of reducing interfacial stress, the curing shrinkage is preferably 8.5% or less, more preferably 7.5% or less, and even more preferably 6.5% or less. If the curing shrinkage is 8.9% or more, the adhesion between the cured product and the substrate will be reduced. The curing shrinkage is not particularly limited, but can be 0%.
[0075] The cure shrinkage of a silsesquioxane derivative is a value calculated according to the following formula (d) after measuring density in accordance with JIS K0061-8 (2001): Cure shrinkage (%) = [(density of cured product - density before curing) / density before curing] x 100 In formula (d), "density before curing" refers to the density of the silsesquioxane derivative. The cure shrinkage (%) was measured using the same method as described in the examples.
[0076] (Preferred Aspect) In the silsesquioxane derivative of the present disclosure, it is preferred that the molar ratio (u / (t+u+v+w+x+y+z)) is 0.45 to 0.65, the molar ratio (v / (t+u+v+w+x+y+z)) is 0.35 to 0.55, the molar ratio (t / (t+u+v+w+x+y+z)), the molar ratio (w / (t+u+v+w+x+y+z)), the molar ratio (x / (t+u+v+w+x+y+z)), the molar ratio (y / (t+u+v+w+x+y+z)), and the molar ratio (z / (t+u+v+w+x+y+z))) are each 0, and at least one of a condensation rate of 78.0% or more and a cure shrinkage rate of 7.5% or less is satisfied. As a result, the silsesquioxane derivative of the present disclosure can form a cured product having excellent adhesion and weather resistance to poorly adhesive substrates by either a heat treatment other than a high-temperature heat treatment (e.g., 110°C) or an active energy ray curing treatment.
[0077] <Method for Producing Silsesquioxane Derivative> The silsesquioxane derivative of the present disclosure can be produced by a known method. The method for producing a silsesquioxane derivative is disclosed in detail in WO 2013 / 031798 and the like as a method for producing polysiloxane.
[0078] In particular, the method for producing a silsesquioxane derivative according to the present disclosure preferably includes a hydrolysis step. In the hydrolysis step, water is added to a mixture of at least one organosilicon compound and an organic solvent to carry out hydrolysis. The organosilicon compound is R n Six p n represents an integer of 0 to 3. p represents an integer of 1 to 4. n+p=4. R represents a group that is bonded to a silicon atom in the silsesquioxane derivative via a carbon atom. X represents a hydrolyzable group. R is a group (H 2 C=CHCOO-R 1 -, H 2 C=C(R 3 ) COO-R 2 - and R 4 ~R 8 Preferred examples of X include an alkoxy group, a silyloxy group, or a halogen atom, and more preferred examples include an alkoxy group or a silyloxy group. The amount of water added is 0.36 to 30 molar equivalents relative to the total amount of hydrolyzable groups in the organosilicon compound.
[0079] In the hydrolysis step, it is preferable to not only hydrolyze the organosilicon compound, but also to carry out hydrolysis and polycondensation reactions of the organosilicon compound and, if necessary, other silicon compounds. In the hydrolysis step, the organosilicon compound and, if necessary, other silicon compounds are hydrolyzed and polycondensed to obtain a silsesquioxane derivative as an intermediate product, and then the obtained intermediate product may be further hydrolyzed and polycondensed with the organosilicon compound, etc.
[0080] When obtaining an intermediate product as described above, after carrying out hydrolysis and polycondensation reactions of the organosilicon compound and, if necessary, other silicon compounds, the obtained intermediate product may be further subjected to hydrolysis and polycondensation reactions of the organosilicon compound in which n is 3 and p is 1. This makes it possible to suitably synthesize a silsesquioxane derivative whose terminal portions are blocked with structural unit (f) derived from the organosilicon compound in which n is 3 and p is 1, thereby suppressing an increase in viscosity of the silsesquioxane derivative and improving its storage stability.
[0081] The method for producing a silsesquioxane derivative according to the present disclosure preferably further comprises a distillation step in which, after the organosilicon compound is subjected to hydrolysis and polycondensation in the presence of a reaction solvent, the reaction solvent, by-products, residual monomers, water, and the like are distilled off from the reaction solution.
[0082] Among the organosilicon compounds, those having an acryloyl group include, for example, (3-acryloyloxypropyl)trimethoxysilane, (3-acryloyloxypropyl)triethoxysilane, (8-acryloyloxyoctyl)trimethoxysilane, and (3-acryloyloxypropyl)trichlorosilane.
[0083] Among the organosilicon compounds, those having a methacryloyl group include, for example, (3-methacryloyloxypropyl)trimethoxysilane, (3-methacryloyloxypropyl)triethoxysilane, (8-methacryloyloxyoctyl)trimethoxysilane, and (3-methacryloyloxypropyl)trichlorosilane.
[0084] Examples of organosilicon compounds that provide two structural units (f) upon hydrolysis include 1,3-divinyltetramethyldisiloxane, 1,3-bis(p-styryl)tetramethyldisiloxane, 1,3-bis(3-acryloyloxypropyl)tetramethyldisiloxane, 1,3-bis(3-methacryloyloxypropyl)tetramethyldisiloxane, methoxydimethylvinylsilane, ethoxydimethylvinylsilane, chlorodimethylvinylsilane, dimethylvinylsilanol, (3-acryloyloxypropyl)dimethylmethoxysilane, (3-methacryloyloxypropyl)dimethylmethoxysilane, p-styryldimethylmethoxysilane, and ethynyldimethylmethoxysilane.
[0085] Examples of silicon compounds that give the structural unit (a) upon hydrolysis include tetramethoxysilane and tetraethoxysilane.
[0086] Examples of the organosilicon compound in which n is 3 and p is 1 include methyltrimethoxysilane, methyltriethoxysilane, ethyltrimethoxysilane, propyltrimethoxysilane, octyltrimethoxysilane, phenyltrimethoxysilane, phenyltriethoxysilane, benzyltrimethoxysilane, cyclohexyltrimethoxysilane, vinyltrimethoxysilane, allyltrimethoxysilane, p-styryltrimethoxysilane, ethynyltrimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, ... trimethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylidene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, N-(vinylbenzyl)-2-aminoethyl-3-aminopropyltrimethoxysilane hydrochloride, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, 3-isocyanatepropyltriethoxysilane, tris(trimethoxysilylpropyl)isocyanurate, 3-mercaptopropyltrimethoxysilane, 3-ethyl-3-[{3-(trimethoxysilyl)propoxy}methyl]oxetane, or 3-ethyl-3-[{3-(triethoxysilyl)propoxy}methyl]oxetane.
[0087] Examples of the organosilicon compound in which n is 2 and p is 2 include dimethyldimethoxysilane, dimethyldiethoxysilane, diethyldidiethoxysilane, propylmethyldimethoxysilane, octylmethyldimethoxysilane, phenylmethyldimethoxysilane, diphenyldiethoxysilane, benzylmethyldimethoxysilane, cyclohexylmethyldimethoxysilane, vinylmethyldimethoxysilane, allylmethyldimethoxysilane, p-styrylmethyldimethoxysilane, ethynylmethyldimethoxysilane, 2-(3,4-epoxycyclohexyl)ethylmethyldimethoxysilane, silane, 3-glycidoxypropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-aminopropylmethyldimethoxysilane, N-phenyl-3-aminopropylmethyldimethoxysilane, N-(vinylbenzyl)-2-aminoethyl-3-aminopropylmethyldimethoxysilane hydrochloride, 3-ureidopropylmethyldialkoxysilane, 3-isocyanatopropylmethyldiethoxysilane, (3-acryloxypropyl)methyldimethoxysilane, or (3-methacryloxypropyl)methyldiethoxysilane.
[0088] Examples of the organosilicon compound in which n is 1 and p is 3 include hexamethyldisiloxane, trimethylmethoxysilane, trimethylethoxysilane, trimethylchlorosilane, and dimethylphenylmethoxysilane.
[0089] In the hydrolysis step, the reaction solvent is not particularly limited, but it is preferable to use an alcohol as the organic solvent. The alcohol is a compound represented by the general formula R—OH. This alcohol is an alcohol in the narrow sense. This alcohol does not have any functional groups other than the alcoholic hydroxyl group. The alcohol is not particularly limited, and examples thereof include methanol, ethanol, 1-propanol, 2-propanol, 2-butanol, 2-pentanol, 3-pentanol, 2-methyl-2-butanol, 3-methyl-2-butanol, cyclopentanol, 2-hexanol, 3-hexanol, 2-methyl-2-pentanol, 3-methyl-2-pentanol, 2-methyl-3-pentanol, 3-methyl-3-pentanol, 2-ethyl-2-butanol, 2,3-dimethyl-2-butanol, and cyclohexanol. Among these, secondary alcohols are preferred. Examples of secondary alcohols include 2-propanol, 2-butanol, 2-pentanol, 3-pentanol, 3-methyl-2-butanol, cyclopentanol, 2-hexanol, 3-hexanol, 3-methyl-2-pentanol, cyclohexanol, etc. In the hydrolysis step, these alcohols may be used alone or in combination of two or more.
[0090] The organic solvent used in the hydrolysis step may be alcohol alone or a mixed solvent of alcohol and at least one auxiliary solvent. The auxiliary solvent may be either a polar solvent or a non-polar solvent, or a combination of both. Examples of organic solvents other than alcohol include xylene, toluene, methyl ethyl ketone, methyl isobutyl ketone, and propylene glycol monomethyl ether.
[0091] The hydrolysis and condensation reactions in the hydrolysis step proceed in the presence of water. In the hydrolysis step, the amount of water added is, from the viewpoints of the condensation rate and cure shrinkage rate, preferably 0.36 to 30 molar equivalents, more preferably 0.4 to 8 molar equivalents, even more preferably 0.5 to 7 molar equivalents, particularly preferably 0.55 to 6 molar equivalents, and most preferably 0.6 to 4 molar equivalents, relative to the total amount of hydrolyzable groups in the organosilicon compound.
[0092] The hydrolysis and polycondensation reaction of the silicon compound may be carried out without a catalyst or may be carried out using a catalyst. When a catalyst is used, inorganic acids (e.g., sulfuric acid, nitric acid, hydrochloric acid, phosphoric acid, etc.), acid catalysts (e.g., formic acid, acetic acid, oxalic acid, paratoluenesulfonic acid, etc.), base catalysts (e.g., ammonia, tetramethylammonium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc.) are preferably used. Acid catalysts are more preferably used. The amount of catalyst used is preferably an amount corresponding to 0.01 mol% to 20 mol%, more preferably an amount corresponding to 0.1 mol% to 10 mol%, based on the total amount (mol) of silicon atoms contained in the silicon compound.
[0093] The completion of the hydrolysis and polycondensation reaction in the hydrolysis step can be appropriately detected by methods described in various publications, etc. In the hydrolysis step of the method for producing a silsesquioxane derivative according to the present disclosure, an auxiliary agent can be added to the reaction system.
[0094] In the method for producing a silsesquioxane derivative of the present disclosure, the stability of the resulting silsesquioxane derivative can be improved by carrying out the distillation step described above after the hydrolysis step. The distillation step can be carried out under normal pressure or reduced pressure, at room temperature or under heating, or under cooling.
[0095] The method for producing a silsesquioxane derivative may include a neutralization step of neutralizing the catalyst before the distillation step, and may also include a step of removing a salt produced by the neutralization by washing with water or the like.
[0096] The silsesquioxane derivative represented by formula (1) (hereinafter also simply referred to as "silsesquioxane derivative") may contain a group formed by ring-opening upon addition of an acid or the like to an oxetanyl group or an epoxy group, among the side-chain functional groups derived from the silicon compound used as a raw material in its production. The silsesquioxane derivative may contain a hydroxyalkyl group formed by decomposition of an organic group having a (meth)acryloyl group. The silsesquioxane derivative may contain a group formed by addition of an acid or the like to an unsaturated hydrocarbon group or the like. Specific examples thereof include those in which a structure represented by formula (A) and / or a structure represented by formula (B) below is included as part of formula (1). The present disclosure can be implemented with a content of 50 mol % or less relative to the amount corresponding to the organic group derived from the silicon compound as a raw material (i.e., the original organic group having an oxetanyl group or an epoxy group, the original organic group having a (meth)acryloyl group, or the original organic group having an unsaturated hydrocarbon group). The content is preferably 30 mol % or less, more preferably 10 mol % or less. In both formulas (A) and (B), T units are exemplified, but similar D units, M units, etc. may also be used.
[0097]
[0098]
[0099] <Curable Composition> The curable composition of the present disclosure contains the silsesquioxane derivative of the present disclosure and a polymerization initiator. The curable composition of the present disclosure may further contain various components (hereinafter also referred to as "other components"), as necessary.
[0100] <<Polymerization initiator>> The polymerization initiator is not particularly limited, and examples thereof include a photopolymerization initiator or a thermal polymerization initiator. Examples of the photopolymerization initiator include a photoradical polymerization initiator. Examples of the thermal polymerization initiator include a thermal radical polymerization initiator. Known compounds may be used as both the photopolymerization initiator and the thermal polymerization initiator.
[0101] Examples of the photoradical polymerization initiator include acetophenone compounds such as 2,2-dimethoxy-1,2-diphenylethan-1-one, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propan-1-one, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one, diethoxyacetophenone, oligo[2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]propanone], or 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)benzyl]phenyl}-2-methyl-propan-1-one; Benzophenone compounds such as benzophenone, 4-phenylbenzophenone, 2,4,6-trimethylbenzophenone, and 4-benzoyl-4'-methyldiphenyl sulfide; α-ketoester compounds such as methylbenzoyl formate, oxyphenylacetic acid 2-[2-oxo-2-phenylacetoxyethoxy]ethyl ester, and oxyphenylacetic acid 2-[2-hydroxyethoxy]ethyl ester; phosphine oxide compounds such as 2,4,6-trimethylbenzoyldiphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, and bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide; benzoin compounds such as benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether; titanocene compounds; Examples of such photoinitiators include acetophenone / benzophenone hybrid photoinitiators such as 1-(4-(4-benzoylphenylsulfanyl)phenyl)-2-methyl-2-(4-methylphenylsulfinyl)propan-1-one; oxime ester photoinitiators such as 1-(4-phenylthiophenyl)-2-(O-benzoyloxime)-1,2-octanedione; and camphorquinone. These may be used alone or in combination of two or more.
[0102] The thermal radical polymerization initiator is not particularly limited, and examples thereof include peroxides and azo-based initiators.
[0103] Examples of peroxides include hydrogen peroxide; inorganic peroxides such as sodium persulfate, ammonium persulfate, and potassium persulfate; 1,1-bis(t-butylperoxy)2-methylcyclohexane, 1,1-bis(t-hexylperoxy)-3,3,5-trimethylcyclohexane, 1,1-bis(t-hexylperoxy)cyclohexane, 1,1-bis(t-butylperoxy)-3,3,5-trimethylcyclohexane, 1,1-bis(t-butylperoxy)cyclohexane, 2,2-bis(4,4-di-butylperoxycyclohexyl)propane, 1,1-bis(t-butylperoxy)cyclohexane, Chlododecane, t-hexylperoxyisopropyl monocarbonate, t-butylperoxymaleic acid, t-butylperoxy-3,5,5-trimethylhexanoate, t-butylperoxylaurate, 2,5-dimethyl-2,5-di(m-toluoylperoxy)hexane, t-butylperoxyisopropyl monocarbonate, t-butylperoxy-2-ethylhexyl monocarbonate, t-hexylperoxybenzoate, 2,5-dimethyl-2,5-di(benzyl) 2,2-bis(t-butylperoxy)hexane, t-butylperoxyacetate, 2,2-bis(t-butylperoxy)butane, t-butylperoxybenzoate, n-butyl-4,4-bis(t-butylperoxy)valerate, di-t-butylperoxyisophthalate, α,α'-bis(t-butylperoxy)diisopropylbenzene, dicumyl peroxide, 2,5-dimethyl-2,5-di(t-butylperoxy)hexane, t-butylcumyl peroxide, di-t- Examples of organic peroxides include butyl peroxide, p-menthane hydroperoxide, 2,5-dimethyl-2,5-di(t-butylperoxy)hexyne-3, diisopropylbenzene hydroperoxide, t-butyltrimethylsilyl peroxide, 1,1,3,3-tetramethylbutyl hydroperoxide, cumene hydroperoxide, t-hexyl hydroperoxide, t-butyl hydroperoxide, and dilauroyl peroxide. These may be used alone or in combination of two or more.
[0104] Examples of azo initiators include azo compounds. Examples of azo compounds include 2,2'-azobisisobutyronitrile, 1,1'-azobis(cyclohexane-1-carbonitrile), 2-(carbamoylazo)isobutyronitrile, 2-phenylazo-4-methoxy-2,4-dimethylvaleronitrile, azodi-t-octane, and azodi-t-butane. These may be used alone or in combination of two or more.
[0105] A redox reaction can also be achieved by combining a peroxide with a redox polymerization initiation system containing a reducing agent, such as ascorbic acid, sodium ascorbate, sodium erythorbate, tartaric acid, citric acid, a metal salt of formaldehyde sulfoxylate, sodium thiosulfate, sodium sulfite, sodium bisulfite, sodium metabisulfite, or ferric chloride.
[0106] In the curable composition of the present disclosure, the content of the polymerization initiator is preferably 0.01 parts by mass to 20 parts by mass, more preferably 0.1 parts by mass to 10 parts by mass, and even more preferably 1 part by mass to 5 parts by mass, relative to 100 parts by mass of the silsesquioxane derivative.
[0107] <Other Components> The curable composition of the present disclosure may contain other components in addition to the polymerization initiator and the silsesquioxane derivative, provided that the effects of the present disclosure are not impaired. The other components of the present disclosure are not particularly limited, and examples thereof include solvents, polymerizable compounds other than silsesquioxane derivatives, resins, silicones, monomers, fillers, surfactants, antistatic agents (e.g., conductive polymers), leveling agents, photosensitizers, UV absorbers, antioxidants, heat resistance improvers, stabilizers, lubricants, pigments, dyes, plasticizers, suspending agents, adhesion promoters, nanoparticles, nanofibers, or nanosheets. The curable composition of the present disclosure may also contain a silane-based reactive diluent. Examples of the silane-based reactive diluent include tetraalkoxysilanes, trialkoxysilanes, dialkoxysilanes, monoalkoxysilanes, and disiloxanes.
[0108] Examples of the solvent include organic solvents. Examples of the organic solvent include aliphatic hydrocarbon solvents, aromatic hydrocarbon solvents, chlorinated hydrocarbon solvents, alcohol solvents, ether solvents, amide solvents, ketone solvents, ester solvents, and cellosolve solvents. The curable composition of the present disclosure may or may not contain a solvent.
[0109] The other polymerizable compound is not particularly limited as long as it is a compound capable of undergoing a polymerization reaction in the presence of a silsesquioxane derivative and a polymerization initiator. Examples of the other polymerizable compound include silsesquioxane derivatives other than silsesquioxane derivatives, (meth)acrylate compounds, compounds having an ethylenically unsaturated group, epoxy compounds (compounds having an epoxy group), compounds having an oxetanyl group (oxetanyl group-containing compounds), and compounds having a vinyl ether group (vinyl ether compounds). The curable composition of the present disclosure may or may not contain a polymerizable compound other than the silsesquioxane derivative (hereinafter also referred to as "other polymerizable compound").
[0110] Examples of the silsesquioxane derivatives other than the silsesquioxane derivatives include silsesquioxane derivatives consisting of only T units, and silsesquioxane derivatives containing T units and D units.
[0111] The (meth)acrylate compound is not particularly limited, and examples thereof include a compound having one (meth)acryloyl group (hereinafter also referred to as a "monofunctional (meth)acrylate"), or a compound having two or more (meth)acryloyl groups (hereinafter also referred to as a "polyfunctional (meth)acrylate").
[0112] Examples of the monofunctional (meth)acrylate include alkyl (meth)acrylates such as methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, and 2-ethylhexyl (meth)acrylate; monofunctional (meth)acrylates having an alicyclic group such as cyclohexyl (meth)acrylate, tert-butylcyclohexyl (meth)acrylate, isobornyl (meth)acrylate, and tricyclodecanemethylol (meth)acrylate; monofunctional (meth)acrylates having an aromatic group such as benzyl (meth)acrylate and phenyl (meth)acrylate; (Meth)acrylates of alkylene oxide adducts of phenol derivatives such as (meth)acrylate of phenol ethylene oxide adduct, (meth)acrylate of phenol propylene oxide adduct, (meth)acrylate of modified nonylphenol ethylene oxide adduct, (meth)acrylate of nonylphenol propylene oxide adduct, (meth)acrylate of alkylene oxide adduct of para-cumylphenol, orthophenylphenol (meth)acrylate, or (meth)acrylate of alkylene oxide adduct of orthophenylphenol; monofunctional (meth)acrylates having an alkoxyalkyl group such as 2-ethylhexyl carbitol (meth)acrylate; monofunctional (meth)acrylates having a heterocycle such as tetrahydrofurfuryl (meth)acrylate or N-(2-(meth)acryloxyethyl)hexahydrophthalimide; Hydroxylalkyl (meth)acrylates such as hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, and hydroxyhexyl (meth)acrylate; monofunctional (meth)acrylates having a hydroxyl group or an aromatic group such as 2-hydroxy-3-phenoxypropyl (meth)acrylate; alkylene glycol mono(meth)acrylates such as diethylene glycol mono(meth)acrylate, dipropylene glycol mono(meth)acrylate, triethylene glycol mono(meth)acrylate, and tripropylene glycol mono(meth)acrylate;and monofunctional (meth)acrylates having a carboxy group such as ω-carboxypolycaprolactone mono(meth)acrylate and monohydroxyethyl phthalate (meth)acrylate.
[0113] Examples of polyfunctional (meth)acrylates include polyethylene glycol di(meth)acrylates such as diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, and tetraethylene glycol di(meth)acrylate; polypropylene glycol di(meth)acrylates such as dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, and tetrapropylene glycol di(meth)acrylate; Examples of the di(meth)acrylate include 1,4-butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, ethylene oxide-modified neopentyl glycol di(meth)acrylate, ethylene oxide-modified bisphenol A di(meth)acrylate, propylene oxide-modified bisphenol A di(meth)acrylate, ethylene oxide-modified hydrogenated bisphenol A di(meth)acrylate, trimethylolpropane di(meth)acrylate, trimethylolpropane allyl ether di(meth)acrylate, trimethylolpropane tri(meth)acrylate, ethylene oxide-modified trimethylolpropane tri(meth)acrylate, propylene oxide-modified trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, and dipentaerythritol hexaacrylate.
[0114] As the polyfunctional (meth)acrylate, a urethane (meth)acrylate can also be used. Examples of the urethane (meth)acrylate include a compound obtained by addition reaction of an organic polyisocyanate with a hydroxyl group-containing (meth)acrylate, or a compound obtained by addition reaction of an organic polyisocyanate with a polyol and a hydroxyl group-containing (meth)acrylate. The monofunctional (meth)acrylate, polyfunctional (meth)acrylate, etc. may be used alone or in combination of two or more types, or different types may be used in combination.
[0115] Examples of polyols include low-molecular-weight polyols, polyether polyols, polyester polyols, and polycarbonate polyols. Examples of low-molecular-weight polyols include ethylene glycol, propylene glycol, neopentyl glycol, cyclohexane dimethylol, and 3-methyl-1,5-pentanediol. Examples of polyether polyols include polypropylene glycol and polytetramethylene glycol. Examples of polyester polyols include reaction products of these low-molecular-weight polyols and / or polyether polyols with an acid component. Examples of acid components include dibasic acids such as adipic acid, succinic acid, phthalic acid, hexahydrophthalic acid, and terephthalic acid, or anhydrides thereof. These may be used alone or in combination of two or more.
[0116] Examples of organic polyisocyanates include tolylene diisocyanate, xylylene diisocyanate, tetramethylxylylene diisocyanate, 4,4'-diphenylmethane diisocyanate, 4,4'-dicyclohexylmethane diisocyanate, hexamethylene diisocyanate, and isophorone diisocyanate. Examples of hydroxyl group-containing (meth)acrylates include hydroxyalkyl (meth)acrylates such as 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, and 4-hydroxybutyl (meth)acrylate; and hydroxyl group-containing polyfunctional (meth)acrylates such as pentaerythritol tri(meth)acrylate, di(meth)acrylate of an adduct of 3 moles of alkylene oxide with isocyanuric acid, and dipentaerythritol penta(meth)acrylate. These may be used alone or in combination of two or more.
[0117] When a (meth)acrylate compound is used in combination with the curable composition of the present disclosure, the blending ratio thereof is not particularly limited. The blending ratio of the (meth)acrylate compound relative to 100 parts by mass of the silsesquioxane derivative is preferably 0 parts by mass to 100 parts by mass, more preferably 0 parts by mass to 50 parts by mass, and even more preferably 0 parts by mass to 20 parts by mass. From the viewpoint of adhesion to the inorganic substance layer, a lower blending ratio of the (meth)acrylate compound is preferable. Specifically, the blending ratio of the (meth)acrylate compound relative to the total amount of the composition is preferably 0 parts by mass to 10 parts by mass, more preferably 0 parts by mass to 5 parts by mass, even more preferably 0 parts by mass to 1 part by mass, and particularly preferably 0 parts by mass.
[0118] A compound having one ethylenically unsaturated group per molecule other than the (meth)acrylate compound may be added to the curable composition. The ethylenically unsaturated group is preferably a (meth)acryloyl group, a maleimide group, a (meth)acrylamide group, or a vinyl group. Examples of the compound having an ethylenically unsaturated group include (meth)acrylic acid, a Michael addition dimer of acrylic acid, N-(2-hydroxyethyl)citraconimide, N,N-dimethylacrylamide, acryloylmorpholine, N-vinylpyrrolidone, and N-vinylcaprolactam. These compounds may be used alone or in combination of two or more.
[0119] Examples of epoxy compounds include monofunctional epoxy compounds and polyfunctional epoxy compounds. Examples of oxetanyl group-containing compounds include monofunctional oxetane compounds and polyfunctional oxetane compounds. Examples of vinyl ether compounds include monofunctional vinyl ether compounds and polyfunctional vinyl ether compounds. For example, compounds described in JP 2011-42755 A may be used as these compounds. There are no particular limitations on the silicone, and known silicones can be used. Examples of silicones include polydimethylsilicone, polydiphenylsilicone, and polymethylphenylsilicone. Silicones preferably have functional groups at their terminals and / or side chains. There are no particular limitations on the functional groups, and examples include (meth)acryloyl groups, epoxy groups, oxetanyl groups, vinyl groups, hydroxyl groups, carboxy groups, amino groups, and thiol groups.
[0120] When the curable composition of the present disclosure contains other polymerizable compounds, the content of the other polymerizable compounds is preferably 0.01 parts by mass to 100 parts by mass, more preferably 0.1 parts by mass to 50 parts by mass, and even more preferably 1 part by mass to 25 parts by mass, relative to 100 parts by mass of the silsesquioxane derivative.
[0121] <Cured Product> The cured product of the present disclosure is obtained by curing the curable composition of the present disclosure. The cured product of the present disclosure can be obtained, for example, by irradiating the curable composition of the present disclosure with active energy rays. The cured product of the present disclosure can be obtained, for example, by heating the curable composition of the present disclosure. When curing the curable composition of the present disclosure, the curable composition may be applied to a substrate, and then the applied product of the curable composition may be cured.
[0122] The elastic modulus at 23°C of the cured product obtained by curing the curable composition, or the hard coat obtained by curing the hard coating agent containing the curable composition, is preferably 2.5 GPa or more, more preferably 3.0 GPa or more, and particularly preferably 3.5 GPa or more. The elastic modulus is preferably 10.0 GPa or less, more preferably 9.5 GPa or less, and particularly preferably 9.0 GPa or less. If the elastic modulus is 2.5 GPa or more, the hardness of the cured product and the hard coat may be improved. If the elastic modulus is 10.0 or less, the flexibility of the cured product and the hard coat may be improved.
[0123] <<Curing Method of Curable Composition>> Methods for curing the curable composition of the present disclosure include active energy ray curing methods and thermal curing methods. Among these, active energy curing methods are preferred from the viewpoints of production efficiency and the range of application of substrates. The curing conditions are not particularly limited. In the case of active energy ray curing methods, a cured product having a desired hardness can be obtained by, for example, appropriately changing the type of light source and the amount of light irradiation. In the case of thermal curing methods, a cured product having a desired hardness can be obtained by appropriately changing the heating temperature, heating time, etc. The type and amount of polymerization initiator and the type of other polymerizable compound contained in the composition are selected as appropriate depending on the curing method.
[0124] (1) Active Energy Ray Curing Method When the present composition is an active energy ray-curable composition, the curing method may involve irradiating the composition with active energy rays using a known active energy ray irradiation device or the like. Examples of active energy rays include electron beams and light (e.g., ultraviolet rays, visible light, X-rays, etc.). Light is preferred, and ultraviolet rays are more preferred from the viewpoint of being able to use inexpensive equipment.
[0125] Examples of ultraviolet irradiation devices include low-pressure mercury lamps, medium-pressure mercury lamps, high-pressure mercury lamps, ultra-high-pressure mercury lamps, metal halide lamps, ultraviolet (UV) electrodeless lamps, chemical lamps, black light lamps, microwave-excited mercury lamps, and light-emitting diodes (LEDs).
[0126] The light irradiation intensity of the coating formed by applying the present composition may be selected depending on the purpose and application, and the light irradiation intensity in the light wavelength region effective for activating the active energy ray polymerization initiator (which is called a photopolymerization initiator in the case of photocurable materials) (this varies depending on the type of photopolymerization initiator, but preferably light with a wavelength of 220 nm to 460 nm is used) is 0.1 mW / cm 2 ~1000mW / cm 2 The irradiation energy should be appropriately set depending on the type of active energy ray, the compounding composition, etc. The light irradiation time of the coating film may be selected depending on the purpose, application, etc. It is preferable that the cumulative light amount is 10 mJ / cm 2 ~7,000mJ / cm 2 The integrated light amount is expressed as the product of the light irradiation intensity in the light wavelength region and the light irradiation time. The integrated light amount is 200 mJ / cm 2 ~5,000mJ / cm 2 More preferably, 500 mJ / cm 2 ~4,000mJ / cm 2 When the integrated light amount is within the above range, the curing of the composition proceeds smoothly, and a uniform cured product can be easily obtained.
[0127] Heat curing can also be combined as appropriate before and / or after photocuring. Two-stage curing can also be performed. In two-stage curing, for example, the composition is impregnated into a substrate having areas that are shaded when irradiated with light, and then the composition is irradiated with light to first cure the areas exposed to light, and then heat is applied to cure the areas not exposed to light. Such substrates are not particularly limited, and examples include substrates with complex shapes (e.g., fabric-like, fibrous, powder-like, porous, or uneven). The shape of the substrate may be a combination of two or more of these shapes.
[0128] (2) Thermal Curing Method When the composition is a thermosetting composition, the curing method and conditions are not particularly limited. The curing temperature is preferably 80°C to 200°C, more preferably 90°C to 150°C, even more preferably 95°C to 130°C, and particularly preferably 100°C to 120°C. The curing temperature may be constant or may be increased. A combination of temperature increase and decrease may also be used. The curing time is appropriately selected depending on the type of thermal polymerization initiator and the content of other components, and is preferably 10 minutes to 360 minutes, more preferably 30 minutes to 300 minutes, and even more preferably 60 minutes to 240 minutes. By curing the composition under the above-mentioned preferred conditions, a uniform cured film free of blistering, cracks, etc. can be formed.
[0129] <<Uses of Curable Composition>> The curable composition of the present disclosure can be used, for example, as a hard coating agent, a sealant, a paint, an ink, a resist, a crosslinking agent, etc. The curable composition of the present disclosure can be suitably used as a hard coating agent from the viewpoint of being able to form a cured product with high hardness.
[0130] <Hard Coating Agent and Hard Coat> The hard coating agent of the present disclosure includes the curable composition of the present disclosure described above. The hard coating of the present disclosure is obtained by curing the hard coating agent of the present disclosure. When the curable composition of the present disclosure is used as a hard coating agent, for example, it is applied to a substrate and dried as necessary to form a coating film made of the hard coating agent. The formed coating is cured by subjecting it to an active energy ray curing treatment or a heat curing treatment, thereby forming a hard coating in which the hard coating agent is cured. This results in an article (preferably a substrate) equipped with a hard coating.
[0131] When the cured composition of the present disclosure is applied to, for example, a substrate, the method for applying the curable composition is not particularly limited. The application method may be a known application method. Examples of application methods include casting, spin coating, bar coating, dip coating, spray coating, roll coating, flow coating, and gravure coating. The thickness of the applied curable composition of the present disclosure is not particularly limited and is, for example, 1 μm to 20 μm.
[0132] Articles of the present disclosure include those requiring surface scratch resistance (for example, substrates, molded articles, etc.) that are provided with the hard coat of the present disclosure.
[0133] There are no particular limitations on the substrate on which a hard coat is formed using the curable composition of the present disclosure. As the substrate, a poorly adhesive substrate is preferred, and a poorly adhesive plastic substrate is more preferred, since the curable composition of the present disclosure exhibits excellent adhesion to poorly adhesive substrates. Examples of poorly adhesive plastics include low-polarity plastics. Suitable examples of low-polarity plastics include olefin polymers. Examples of olefin polymers include polyethylene (PE), polypropylene (PP), cycloolefin polymers (COP), and cycloolefin copolymers (COC). Among olefin polymers, COP and COC are particularly preferred.
[0134] The shape of the substrate is not particularly limited, and examples thereof include plate-like, sheet-like, film-like, rod-like, spherical, fibrous, powder-like, lenticular, and other regular or irregular shapes.
[0135] <Laminate> The laminate of the present disclosure has the hard coat of the present disclosure described above and a substrate. Details of the substrate are the same as those of the substrate in the article section, and preferred embodiments are also the same. The substrate in the laminate preferably contains an olefin polymer, and the olefin polymer is the same as that of the olefin polymer in the article section, and preferred embodiments are also the same.
[0136] Next, the present disclosure will be specifically described based on examples and comparative examples, but the present disclosure is not limited to the following examples.
[0137] <Synthesis of Silsesquioxane Derivatives> (Examples 1 and 5) A 1-L four-neck round-bottom flask equipped with a thermometer, dropping funnel, and stirring blade was prepared. (3-acryloyloxy)propyltrimethoxysilane (140.6 g, 0.6 mol), (3-methacryloyloxy)propyltrimethoxysilane (99.3 g, 0.4 mol), 2-propanol (64.6 g), and hydroquinone (0.085 g) were weighed into the flask and stirred thoroughly in a water bath at approximately 30°C. Separately, an aqueous solution was prepared by mixing 35% hydrochloric acid (1.0 g, 9.6 mmol as hydrogen chloride) and pure water (150.7 g). The prepared aqueous solution was added dropwise to the mixture from the dropping funnel over approximately 1 hour while stirring the reaction solution, and then allowed to stand overnight at room temperature. The amount of water added was 2.8 times the total amount of hydrolyzable groups in the starting organosilicon compound (amount of water added: 2.8 molar equivalents). The reaction solution was then heated to 60°C while the solvent and other components in the reaction solution were distilled off under reduced pressure, yielding 170 g each of silsesquioxane derivatives 1 and 5 as colorless, transparent liquids. 1 H-NMR analysis confirmed that each structural unit in the silsesquioxane derivatives 1 and 5 was quantitatively introduced in the ratio of the raw materials used.
[0138] Example 2 A silsesquioxane derivative 2 was obtained in the same manner as in Examples 1 and 5, except that the amount of water added during synthesis of the silsesquioxane derivative was changed to 1.0 molar equivalent.
[0139] Example 3 Dimethoxydimethylsilane (structural unit (e)) was used instead of (3-methacryloyloxy)propyltrimethoxysilane (structural unit (c)), which was used as a raw material for silsesquioxane derivative 1 in Example 1. The amounts of raw materials charged and the amount of water added during synthesis of the silsesquioxane derivative were changed as shown in Table 1, and the amounts of solvent, etc. were also changed appropriately. Other than the above, silsesquioxane derivative 3 was obtained in the same manner as in Example 1.
[0140] Example 4 Only (3-acryloyloxy)propyltrimethoxysilane (structural unit (b)) was used as the raw material for silsesquioxane derivative 1. The amounts of raw materials charged and the amount of water added during synthesis of the silsesquioxane derivative were changed as shown in Table 1, and the amounts of solvent, etc. were also changed appropriately. Other than the above, silsesquioxane derivative 4 was obtained in the same manner as in Example 1.
[0141] Example 6 In addition to the raw materials for silsesquioxane derivative 1 in Example 1, 1,3-divinyltetramethyldisiloxane (structural unit (f)) was used. The amounts of raw materials charged and the amount of water added during synthesis of the silsesquioxane derivative were changed as shown in Table 1, and the amounts of solvent, etc. were also changed appropriately. Other than the above, silsesquioxane derivative 6 was obtained in the same manner as in Example 1.
[0142] Comparative Example 1 Only (3-methacryloyloxy)propyltrimethoxysilane (structural unit (c)) was used as the raw material for the silsesquioxane derivative. The amounts of raw materials charged and the amount of water added during synthesis of the silsesquioxane derivative were changed as shown in Table 1, and the amounts of solvent, etc. were also changed appropriately. Other than the above, the same procedure as in Example 1 was used to obtain a comparative silsesquioxane derivative c1.
[0143] Comparative Example 2 Only (3-acryloyloxy)propyltrimethoxysilane (structural unit (b)) was used as the raw material for the silsesquioxane derivative. The amounts of raw materials charged and the amount of water added during synthesis of the silsesquioxane derivative were changed as shown in Table 1, and the amounts of solvent, etc. were also changed appropriately. Other than the above, the same procedure as in Example 1 was used to obtain a comparative silsesquioxane derivative c2.
[0144] <Calculation of Condensation Ratio> When calculating the condensation ratio, the silsesquioxane derivatives of Examples 1 to 6, Comparative Example 1, and Comparative Example 2 were 29 Si-NMR measurement was carried out to obtain a spectrum. 29 From the spectrum obtained by Si-NMR measurement, calculation was performed according to the following formulas (a) to (c) using the ratio of the integral values of the peaks corresponding to D units consisting of M1 units, D1 units, and D2 units, and T units consisting of T1 units, T2 units, and T3 units. Formula (a): Condensation rate (%) = integral of silicon corresponding to condensed siloxane bonds / integral of silicon corresponding to all condensable siloxane bonds × 100 Formula (b): integral of silicon corresponding to condensed siloxane bonds = [M1] × 1 + [D1] × 1 + [D2] × 2 + [T1] × 1 + [T2] × 2 + [T3] × 3 Formula (c): integral of silicon corresponding to all condensable siloxane bonds = ([M0] + [M1]) × 1 + ([D0] + [D1] + [D2]) × 2 + ([T0] + [T1] + [T2] + [T3]) × 3
[0145] <Calculation of cure shrinkage> The cure shrinkage was calculated using photocured products (Examples 1 to 4, Example 6, Comparative Examples 1 and 2) and a thermocured product (Example 5). The photocured products and thermocured products were prepared as follows.
[0146] (Preparation of Photocurable Composition) 0.03 parts by mass of 2-hydroxy-2-methyl-1-phenylpropan-1-one was added to 1 part by mass of the silsesquioxane derivative of Examples 1 to 4, Example 6, Comparative Example 1, and Comparative Example 2, and the mixture was stirred with a planetary centrifugal mixer to obtain a photocurable composition.
[0147] (Preparation of Photocured Product) A photocurable composition was poured into a silicone mold on a release polyethylene terephthalate (PET) film, a release PET film was placed on top of it, and the resulting structure was sandwiched and fixed between glass plates. The fixed photocurable composition was then irradiated with ultraviolet light under the following conditions to cure, thereby obtaining a photocured product. -Ultraviolet Irradiation Conditions- Lamp: High-pressure mercury lamp Lamp height: 10 cm Conveyor speed: 5.75 m / min Integrated light intensity per pass: 360 mJ / cm 2 (UV-A) Atmosphere: Air Number of passes: 20 times
[0148] (Preparation of Thermosetting Composition) 0.02 parts by mass of dilauroyl peroxide was added to 1 part by mass of the silsesquioxane derivative of Example 5, and the mixture was stirred with a planetary centrifugal mixer to obtain a thermosetting composition.
[0149] A thermosetting composition was poured into a silicone mold on a release polyethylene terephthalate (PET) film, and the mold was then covered with a release PET film. The resulting structure was sandwiched between glass plates and fixed in place. The fixed thermosetting composition was then heated at 110°C for 4 hours to cure, yielding a thermoset product.
[0150] The density of the photocured and thermoset products obtained above was measured in accordance with JIS K0061-8 (2001). The obtained values were used to calculate the cure shrinkage using the following formula. The results are shown in Table 1. Formula (d): cure shrinkage (%) = [(density of cured product - density before curing) / density before curing] x 100 In formula (d), "density before curing" refers to the density of the silsesquioxane derivative.
[0151] <Weather Resistance Test> For the weather resistance test, photocured films (Examples 1 to 4, Example 6, Comparative Example 1, and Comparative Example 2) and a thermocured film (Example 5) were used. The photocured films and thermocured films were prepared as follows.
[0152] (Preparation of Photocurable Coating Liquid) 0.03 parts by mass of 2-hydroxy-2-methyl-1-phenylpropan-1-one and 1 part by mass of propylene glycol monobutyl ether were added to 1 part by mass of a silsesquioxane derivative to obtain a mixture. The obtained mixture was stirred with a planetary centrifugal mixer to obtain a photocurable coating liquid.
[0153] (Preparation of Photocured Film) A photocurable coating liquid was applied to a cycloolefin copolymer (APL5015AL manufactured by Mitsui Chemicals, Inc., APL5014DP manufactured by Mitsui Chemicals, Inc.) or a cycloolefin polymer (ZEONEX 480R manufactured by Zeon Corporation) using a No. 8 bar coater, and dried at 60°C for 5 minutes. The applied photocurable coating liquid was then irradiated with ultraviolet light under the following conditions to cure the applied photocurable coating liquid. This resulted in a photocured film with a film thickness of approximately 5 μm. -Ultraviolet Irradiation Conditions- Lamp: High-pressure mercury lamp Lamp height: 10 cm Conveyor speed: 5.75 m / min Integrated light intensity per pass: 360 mJ / cm 2 (UV-A) Atmosphere: Air Number of passes: 10
[0154] (Preparation of thermosetting coating liquid) 0.02 parts by mass of dilauroyl peroxide and 1 part by mass of propylene glycol monobutyl ether were added to 1 part by mass of a silsesquioxane derivative to obtain a mixture. The mixture was stirred with a planetary centrifugal mixer to obtain a thermosetting coating liquid.
[0155] (Preparation of Thermosetting Film) A thermosetting coating liquid was applied to a cycloolefin copolymer (APL5015AL manufactured by Mitsui Chemicals, Inc.) using a No. 8 bar coater, and the applied thermosetting coating liquid was cured by heating at 110°C for 4 hours in an air atmosphere. As a result, a thermosetting film with a film thickness of approximately 5 μm was obtained. Note that the heating treatment at 110°C was not a high-temperature heating treatment.
[0156] The photocured and thermocured films obtained above were subjected to a cross-cut test in accordance with JIS K5600-5-6. The results are shown in Table 1 as the results before the weather resistance test. The photocured and thermocured films were left to stand in an environment of 85°C and 85% RH for 250 hours, and then the cross-cut test was performed in accordance with JIS K5600-5-6. The results are shown in Table 1 as the results after the weather resistance test. In Table 1, "-" indicates that the test was not performed. Weather resistance was evaluated based on the remaining mass ratio, which was calculated according to the following formula (e): Formula (e): remaining mass ratio (%) = (number of remaining squares) / (number of squares) × 100 A remaining mass ratio of 90% or more was evaluated as "A." A remaining mass ratio of 30% or more but less than 90% was evaluated as "B." A remaining mass ratio of less than 30% was evaluated as "C."
[0157] <Pencil Hardness Test> The photocured film and thermocured film obtained above were subjected to a pencil hardness test in accordance with JIS K-5600-5-4 (1999). The results are shown in Table 1. In Table 1, "-" indicates that the test was not performed.
[0158] <Elastic Modulus Measurement> The elastic modulus of the photocured film and thermocured film obtained above was measured as follows. Indentation hardness was measured at 23°C at a strain rate of 0.05 / s using a nanoindenter (Nano Indenter G200 manufactured by Agilent Technologies, using a Berkovich indenter). The elastic modulus was calculated by averaging the modulus values at indentation depths of 100 nm to 400 nm. The results are shown in Table 1. In Table 1, "-" indicates that the test was not performed.
[0159]
[0160] As shown in Table 1, the silsesquioxane derivatives of Examples 1 to 6 were shown to have excellent adhesion and weather resistance to poorly adhesive substrates, cycloolefin copolymers and cycloolefin polymers, even without high-temperature heat treatment. On the other hand, the silsesquioxane derivatives of Comparative Examples 1 and 2 were shown to have insufficient adhesion and weather resistance to poorly adhesive substrates, cycloolefin copolymers and cycloolefin polymers.
[0161] The disclosure of Japanese Patent Application No. 2023-090431, filed on May 31, 2023, is incorporated herein by reference in its entirety. All documents, patent applications, and technical standards described herein are incorporated herein by reference to the same extent as if each individual document, patent application, and technical standard was specifically and individually indicated to be incorporated by reference.
Claims
1. A silsesquioxane derivative represented by the following formula (1), having a condensation rate of 72.0% or more and a cure shrinkage rate of less than 8.9%. [In formula (1), R 1 and R 2 each independently represents an alkylene group having 1 to 10 carbon atoms, a cycloalkylene group having 3 to 10 carbon atoms, an arylene group having 6 to 10 carbon atoms, or an aralkylene group having 7 to 12 carbon atoms; R 3 is an alkyl group having 1 to 6 carbon atoms; R 4 and R 5 each independently represents a hydrogen atom, a saturated or unsaturated alkyl group having 1 to 20 carbon atoms, a saturated or unsaturated cycloalkyl group having 3 to 8 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an aralkyl group having 7 to 20 carbon atoms; R 6 is an organic group having 2 to 12 carbon atoms and at least one of an ethylenically unsaturated bond and a carbon-carbon triple bond, R 7 and R 8 are each independently an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 10 carbon atoms, or an aralkyl group having 7 to 10 carbon atoms, 5 may be the same or different, and multiple R 7 may be the same or different, and multiple R 8 may be the same or different, R 1 ~R 8 may each independently be partially substituted with a substituent or a halogen atom, t, u, v, w, x, y and z each independently represent 0 or a positive number, and at least one of u and v is a positive number.
2. The silsesquioxane derivative according to claim 1, wherein u is a positive number, and v, x and y are each independently 0 or a positive number.
3. The silsesquioxane derivative according to claim 1, wherein u and v are each independently a positive number.
4. A curable composition comprising the silsesquioxane derivative according to any one of claims 1 to 3 and a polymerization initiator.
5. A cured product obtained by curing the curable composition according to claim 4.
6. A hard coat agent comprising the curable composition according to claim 4.
7. A hard coat obtained by curing the hard coat agent according to claim 6.
8. An article having the hard coat according to claim 7.
9. A laminate comprising the hard coat according to claim 7 and a substrate.
10. The laminate of claim 9, wherein the substrate comprises an olefin polymer.
Citation Information
Patent Citations
High-refractive index silicon resin and preparation method thereof
CN102690416A
Reactive organic-inorganic composite particle
JP1997031343A
Polymer fine particles and production process thereof, conductive fine particles
JP2006117850A
Curable resin composition, and molded article obtained from the same
JP2011195750A
Nanofiber-reinforced transparent composite material
JP2012062457A
